Matt Dormer is a seasoned professional in healthcare investment banking, currently serving as Managing Director for Health & Life Sciences Investment Banking at Stephens since September 2022. Dormer has extensive experience with biotech, specialty pharmaceuticals, and medical device companies, providing a range of services that include IPOs, public offerings, private placements, reverse mergers/APOs, and M&A advisory. Previous roles include Managing Director positions at Oppenheimer & Co. Inc. and Laidlaw & Company UK Ltd., where similar services were offered to both private and publicly traded healthcare clients. Dormer's career began as an Associate Biotech Analyst at Fulcrum Global Partners, and educational achievements include a BS in Biology from Davidson College and an MBA in Finance from Northeastern University. Dormer holds multiple NASD licenses, including Series 7, 63, 79, 86, and 87.
This person is not in any teams
This person is not in any offices